Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 13.3

(-2.56%)

Eps Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual eps in 2023 was -0.11 TWD , down -33.33% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly eps in 2024 Q2 was -0.02 TWD , down -10.0% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported an annual eps of -0.08 TWD in 2022, down -331.94% from previous year.
  • Mercury Biopharmaceutical Corporation reported an annual eps of -0.02 TWD in 2021, down -855.0% from previous year.
  • Mercury Biopharmaceutical Corporation reported a quarterly eps of -0.02 TWD for 2024 Q1, up 33.77% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a quarterly eps of -0.02 TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Eps Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Eps of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Eps Eps Growth
2023 -0.11 TWD -33.33%
2022 -0.08 TWD -331.94%
2021 -0.02 TWD -855.0%
2020 -0.00 TWD -233.33%
2019 -0.00 TWD 0.0%

Peer Eps Comparison of Mercury Biopharmaceutical Corporation